Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 3/20 | 0.46 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.46 |
| ▸ | MMP3 | P08254 | 2/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6829825 | 0.87 | TDP1 (0.49) | CA1CA2CA12CA7CA9 | |
| SCHEMBL14809991 | 0.87 | CA12 (0.43) | MMP9ADAM17MMP3MMP1CA1 | |
| SCHEMBL11609892 | 0.82 | MMP9 (0.45) | MMP9ADAM17MMP3MMP1CA1 | |
| SCHEMBL9407115 | 0.81 | TDP1 (0.45) | CA1CA2CA12CA7CA9 | |
| SCHEMBL16868490 | 0.81 | MMP9 (0.47) | MMP9ADAM17MMP3MMP1CA1 | |
| SCHEMBL11343746 | 0.81 | MMP9 (0.44) | MMP9ADAM17MMP3MMP1CA1 | |
| SCHEMBL459400 | 0.80 | ALDH1A1 (0.44) | CA1CA2CA12CA7CA9 | |
| SCHEMBL107781 | 0.79 | HPGD (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL10721682 | 0.79 | CA1 (0.52) | CA1CA2CA12CA7CA9 | |
| SCHEMBL1001220 | 0.78 | CA1 (0.58) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8062816-B2 | Phosphonate hole blocking layer photoconductors | XEROX CORPORATION (US) | 2011-11-22 | — | — | US | claimed |
| US-8053151-B2 | Phosphonate containing photoconductors | XEROX CORPORATION (US) | 2011-11-08 | — | — | US | claimed |
| EP-2141545-A1 | Phosphonate containing photoconductors | Xerox Corporation (US) | 2010-01-06 | — | — | EP | claimed |
| US-20090325091-A1 | PHOSPHONATE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-31 | — | — | US | claimed |
| US-20090297967-A1 | PHOSPHONATE HOLE BLOCKING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-03 | — | — | US | claimed |
| EP-2128709-A1 | Phosphonate Hole Blocking Layer Photoconductors | Xerox Corporation (US) | 2009-12-02 | — | — | EP | claimed |
| CN-116425794-A | Aryl phosphonate compound and preparation method thereof | 烟台大学 | 2023-07-14 | — | — | CN | disclosed |
| CN-111032737-B | Ethylene imine polymer solution and method for producing same | 株式会社日本触媒 | 2022-06-14 | — | — | CN | disclosed |
| CN-111032737-A | Ethylene imine polymer solution and method for producing same | 株式会社日本触媒 | 2020-04-17 | — | — | CN | disclosed |
| WO-2015031725-A1 | TRANSITION METAL-CATALYZED IMIDATION OF ARENES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-03-05 | — | — | WO | disclosed |
| EP-1827688-B1 | NOVEL METATHESIS RUTHENIUM CATALYST | BOEHRINGER INGELHEIM INT (DE) | 2014-09-03 | — | — | EP | disclosed |
| US-8062816-B2 | Phosphonate hole blocking layer photoconductors | XEROX CORPORATION (US) | 2011-11-22 | — | — | US | disclosed |
| US-8053151-B2 | Phosphonate containing photoconductors | XEROX CORPORATION (US) | 2011-11-08 | — | — | US | disclosed |
| US-20090297967-A1 | PHOSPHONATE HOLE BLOCKING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-03 | — | — | US | disclosed |
| EP-2128709-A1 | Phosphonate Hole Blocking Layer Photoconductors | Xerox Corporation (US) | 2009-12-02 | — | — | EP | disclosed |
| EP-1827688-A1 | NOVEL METATHESIS RUTHENIUM CATALYST | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-09-05 | — | — | EP | disclosed |
| US-7109344-B2 | Prepared from 2-alkoxy-5-styrene derivatives, used for ring-closing metathesis, cross metathesis or ene-ine metathesis reactions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-09-19 | — | — | US | disclosed |
| US-20050143580-A1 | Novel ruthenium catalyst | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-06-30 | — | — | US | disclosed |
| EP-1543875-A1 | Novel metathesis ruthenium catalyst | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2005-06-22 | — | — | EP | disclosed |
| WO-2005053843-A1 | NOVEL METATHESIS RUTHENIUM CATALYST | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143580-A1 | Novel ruthenium catalyst | CCNE1, CCNE2, RER1 | MMP9 3158/4885ADAM17 4037/4885MMP3 2567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.